Logo image of PSIX

POWER SOLUTIONS INTERNATIONA (PSIX) Stock Fundamental Analysis

NASDAQ:PSIX - Nasdaq - US73933G2021 - Common Stock - Currency: USD

53.53  +3.6 (+7.21%)

After market: 54.8 +1.27 (+2.37%)

Fundamental Rating

6

Overall PSIX gets a fundamental rating of 6 out of 10. We evaluated PSIX against 94 industry peers in the Electrical Equipment industry. PSIX gets an excellent profitability rating and is at the same time showing great financial health properties. PSIX has a correct valuation and a medium growth rate. These ratings could make PSIX a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PSIX was profitable.
PSIX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PSIX reported negative net income in multiple years.
In multiple years PSIX reported negative operating cash flow during the last 5 years.
PSIX Yearly Net Income VS EBIT VS OCF VS FCFPSIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of PSIX (21.80%) is better than 98.94% of its industry peers.
PSIX's Return On Equity of 96.33% is amongst the best of the industry. PSIX outperforms 100.00% of its industry peers.
The Return On Invested Capital of PSIX (31.06%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PSIX is significantly above the industry average of 9.87%.
The last Return On Invested Capital (31.06%) for PSIX is above the 3 year average (27.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 21.8%
ROE 96.33%
ROIC 31.06%
ROA(3y)11.3%
ROA(5y)1.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)27.16%
ROIC(5y)N/A
PSIX Yearly ROA, ROE, ROICPSIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

PSIX's Profit Margin of 15.74% is amongst the best of the industry. PSIX outperforms 94.68% of its industry peers.
PSIX's Profit Margin has improved in the last couple of years.
PSIX's Operating Margin of 18.52% is amongst the best of the industry. PSIX outperforms 94.68% of its industry peers.
In the last couple of years the Operating Margin of PSIX has grown nicely.
Looking at the Gross Margin, with a value of 30.04%, PSIX is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
PSIX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.52%
PM (TTM) 15.74%
GM 30.04%
OM growth 3YN/A
OM growth 5Y40.35%
PM growth 3YN/A
PM growth 5Y57.51%
GM growth 3Y48.31%
GM growth 5Y10.05%
PSIX Yearly Profit, Operating, Gross MarginsPSIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PSIX is creating value.
PSIX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, PSIX has more shares outstanding
The debt/assets ratio for PSIX has been reduced compared to a year ago.
PSIX Yearly Shares OutstandingPSIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
PSIX Yearly Total Debt VS Total AssetsPSIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

PSIX has an Altman-Z score of 4.47. This indicates that PSIX is financially healthy and has little risk of bankruptcy at the moment.
PSIX's Altman-Z score of 4.47 is fine compared to the rest of the industry. PSIX outperforms 79.79% of its industry peers.
PSIX has a debt to FCF ratio of 2.29. This is a good value and a sign of high solvency as PSIX would need 2.29 years to pay back of all of its debts.
PSIX's Debt to FCF ratio of 2.29 is amongst the best of the industry. PSIX outperforms 86.17% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that PSIX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.31, PSIX is doing worse than 72.34% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for PSIX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 2.29
Altman-Z 4.47
ROIC/WACC3.12
WACC9.95%
PSIX Yearly LT Debt VS Equity VS FCFPSIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

PSIX has a Current Ratio of 1.16. This is a normal value and indicates that PSIX is financially healthy and should not expect problems in meeting its short term obligations.
PSIX has a Current ratio of 1.16. This is in the lower half of the industry: PSIX underperforms 67.02% of its industry peers.
A Quick Ratio of 0.67 indicates that PSIX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.67, PSIX is doing worse than 72.34% of the companies in the same industry.
PSIX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.67
PSIX Yearly Current Assets VS Current LiabilitesPSIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 152.27% over the past year.
The Earnings Per Share has been growing by 51.27% on average over the past years. This is a very strong growth
Looking at the last year, PSIX shows a quite strong growth in Revenue. The Revenue has grown by 17.90% in the last year.
The Revenue has been decreasing by -2.71% on average over the past years.
EPS 1Y (TTM)152.27%
EPS 3YN/A
EPS 5Y51.27%
EPS Q2Q%167.74%
Revenue 1Y (TTM)17.9%
Revenue growth 3Y1.42%
Revenue growth 5Y-2.71%
Sales Q2Q%42.22%

3.2 Future

Based on estimates for the next years, PSIX will show a small growth in Earnings Per Share. The EPS will grow by 7.78% on average per year.
Based on estimates for the next years, PSIX will show a quite strong growth in Revenue. The Revenue will grow by 9.76% on average per year.
EPS Next Y9.26%
EPS Next 2Y7.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.18%
Revenue Next 2Y9.76%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PSIX Yearly Revenue VS EstimatesPSIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PSIX Yearly EPS VS EstimatesPSIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.08, PSIX is valued correctly.
Based on the Price/Earnings ratio, PSIX is valued cheaply inside the industry as 87.23% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PSIX to the average of the S&P500 Index (26.57), we can say PSIX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.40, the valuation of PSIX can be described as correct.
PSIX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PSIX is cheaper than 79.79% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.41, PSIX is valued a bit cheaper.
Industry RankSector Rank
PE 16.08
Fwd PE 16.4
PSIX Price Earnings VS Forward Price EarningsPSIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PSIX indicates a rather cheap valuation: PSIX is cheaper than 88.30% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PSIX is valued cheaper than 80.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.44
EV/EBITDA 10.91
PSIX Per share dataPSIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PSIX may justify a higher PE ratio.
PEG (NY)1.74
PEG (5Y)0.31
EPS Next 2Y7.78%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PSIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POWER SOLUTIONS INTERNATIONA

NASDAQ:PSIX (6/16/2025, 5:20:00 PM)

After market: 54.8 +1.27 (+2.37%)

53.53

+3.6 (+7.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-11 2025-08-11
Inst Owners13.66%
Inst Owner Change43.54%
Ins Owners1.7%
Ins Owner Change-16.6%
Market Cap1.23B
Analysts82.86
Price Target65.28 (21.95%)
Short Float %5.57%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.56%
Min EPS beat(2)26.23%
Max EPS beat(2)76.9%
EPS beat(4)4
Avg EPS beat(4)55.44%
Min EPS beat(4)22.55%
Max EPS beat(4)96.08%
EPS beat(8)8
Avg EPS beat(8)82.39%
EPS beat(12)12
Avg EPS beat(12)362.6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.56%
Min Revenue beat(2)0.55%
Max Revenue beat(2)24.57%
Revenue beat(4)2
Avg Revenue beat(4)4.87%
Min Revenue beat(4)-4.98%
Max Revenue beat(4)24.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)1.1%
Revenue beat(16)6
Avg Revenue beat(16)-1.01%
PT rev (1m)0%
PT rev (3m)16.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)35.94%
EPS NY rev (1m)0%
EPS NY rev (3m)5.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.04%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 16.4
P/S 2.39
P/FCF 25.44
P/OCF 22.16
P/B 14.6
P/tB 23.52
EV/EBITDA 10.91
EPS(TTM)3.33
EY6.22%
EPS(NY)3.26
Fwd EY6.1%
FCF(TTM)2.1
FCFY3.93%
OCF(TTM)2.42
OCFY4.51%
SpS22.43
BVpS3.67
TBVpS2.28
PEG (NY)1.74
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 21.8%
ROE 96.33%
ROCE 71.77%
ROIC 31.06%
ROICexc 39.1%
ROICexgc 46.85%
OM 18.52%
PM (TTM) 15.74%
GM 30.04%
FCFM 9.38%
ROA(3y)11.3%
ROA(5y)1.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)27.16%
ROIC(5y)N/A
ROICexc(3y)36.27%
ROICexc(5y)N/A
ROICexgc(3y)71.34%
ROICexgc(5y)N/A
ROCE(3y)1434.71%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y25.96%
ROICexc growth 3YN/A
ROICexc growth 5Y30.55%
OM growth 3YN/A
OM growth 5Y40.35%
PM growth 3YN/A
PM growth 5Y57.51%
GM growth 3Y48.31%
GM growth 5Y10.05%
F-Score5
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 2.29
Debt/EBITDA 1.1
Cap/Depr 138.4%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 55.14%
Profit Quality 59.6%
Current Ratio 1.16
Quick Ratio 0.67
Altman-Z 4.47
F-Score5
WACC9.95%
ROIC/WACC3.12
Cap/Depr(3y)65.93%
Cap/Depr(5y)50.73%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.27%
EPS 3YN/A
EPS 5Y51.27%
EPS Q2Q%167.74%
EPS Next Y9.26%
EPS Next 2Y7.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.9%
Revenue growth 3Y1.42%
Revenue growth 5Y-2.71%
Sales Q2Q%42.22%
Revenue Next Year11.18%
Revenue Next 2Y9.76%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y106.09%
EBIT growth 3YN/A
EBIT growth 5Y36.55%
EBIT Next Year13.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y314.23%
FCF growth 3YN/A
FCF growth 5Y31.91%
OCF growth 1Y310.72%
OCF growth 3YN/A
OCF growth 5Y28%